We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
This guide is about infections that occur in people who inject drugs (PWID).
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Check what side effects people have reported when they have taken a medicine.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
How to use a micro-randomised trial to evaluate your digital health product.
This 2-arm randomized controlled trial was undertaken at an HIV clinic in a district hospital in Uganda
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).